SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Chi-Shin Wu, Ming H. Hsieh, Chao-Hsiun Tang, Ching-Jui Chang, Comparative effectiveness of long-acting injectable risperidone vs. long-acting injectable first-generation antipsychotics in bipolar disorder, Journal of Affective Disorders, 2016, 197, 189

    CrossRef

  2. 2
    Consider second-generation antipsychotics for the management of mixed states in bipolar disorder, Drugs & Therapy Perspectives, 2016,

    CrossRef

  3. 3
    Dong-Jing Fu, Ibrahim Turkoz, Cynthia A. Bossie, Hiren Patel, Larry Alphs, Rapid onset of treatment effects on psychosis, depression, and mania in patients with acute exacerbation of schizoaffective disorder following treatment with oral extended-release paliperidone, Journal of Affective Disorders, 2016, 193, 381

    CrossRef

  4. 4
    Michael Berger, Ute Lewitzka, Florian Seemüller, Akutbehandlung manischer Episoden, DNP - Der Neurologe und Psychiater, 2015, 16, 12, 47

    CrossRef

  5. 5
    Andrea Fagiolini, Anna Coluccia, Giuseppe Maina, Rocco N. Forgione, Arianna Goracci, Alessandro Cuomo, Allan H. Young, Diagnosis, Epidemiology and Management of Mixed States in Bipolar Disorder, CNS Drugs, 2015, 29, 9, 725

    CrossRef

  6. 6
    Isabella Pacchiarotti, Andrea Murru, Georgios D. Kotzalidis, C. Mar Bonnin, Lorenzo Mazzarini, Francesc Colom, Eduard Vieta, Hyperprolactinemia and medications for bipolar disorder: Systematic review of a neglected issue in clinical practice, European Neuropsychopharmacology, 2015, 25, 8, 1045

    CrossRef

  7. 7
    Iria Grande, Eduard Vieta, Pharmacotherapy of Acute Mania: Monotherapy or Combination Therapy with Mood Stabilizers and Antipsychotics?, CNS Drugs, 2015, 29, 3, 221

    CrossRef

  8. 8
    Heinz Grunze, Jean Michel Azorin, Clinical decision making in the treatment of mixed states, The World Journal of Biological Psychiatry, 2014, 15, 5, 355

    CrossRef

  9. 9
    Othman Mohammad, David N. Osser, The Psychopharmacology Algorithm Project at the Harvard South Shore Program, Harvard Review of Psychiatry, 2014, 22, 5, 274

    CrossRef

  10. 10
    Tomoya Hirota, Taro Kishi, Adenosine hypothesis in schizophrenia and bipolar disorder: A systematic review and meta-analysis of randomized controlled trial of adjuvant purinergic modulators, Schizophrenia Research, 2013, 149, 1-3, 88

    CrossRef

  11. 11
    Lakshmi N Yatham, Sidney H Kennedy, Sagar V Parikh, Ayal Schaffer, Serge Beaulieu, Martin Alda, Claire O’Donovan, Glenda MacQueen, Roger S McIntyre, Verinder Sharma, Arun Ravindran, L Trevor Young, Roumen Milev, David J Bond, Benicio N Frey, Benjamin I Goldstein, Beny Lafer, Boris Birmaher, Kyooseob Ha, Willem A Nolen, Michael Berk, Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013, Bipolar Disorders, 2013, 15, 1
  12. 12
    Kesavan Muralidharan, Mazen Ali, Leonardo E. Silveira, David J. Bond, Konstantinos N. Fountoulakis, Raymond W. Lam, Lakshmi N. Yatham, Efficacy of second generation antipsychotics in treating acute mixed episodes in bipolar disorder: A meta-analysis of placebo-controlled trials, Journal of Affective Disorders, 2013, 150, 2, 408

    CrossRef

  13. 13
    J.M. Goikolea, F. Colom, I. Torres, J. Capapey, M. Valentí, J. Undurraga, I. Grande, J. Sanchez-Moreno, E. Vieta, Lower rate of depressive switch following antimanic treatment with second-generation antipsychotics versus haloperidol, Journal of Affective Disorders, 2013, 144, 3, 191

    CrossRef

  14. 14
    Ya-Mei Bai, Ching-Jui Chang, Shang-Ying Tsai, Yi-Chyan Chen, Mei-Chun Hsiao, Cheng-Ta Li, Peichi Tu, Shang-Wen Chang, Winston W. Shen, Tung-Ping Su, Taiwan consensus of pharmacological treatment for bipolar disorder, Journal of the Chinese Medical Association, 2013, 76, 10, 547

    CrossRef

  15. 15
    Joris Berwaerts, Rama Melkote, Isaac Nuamah, Pilar Lim, A randomized, placebo- and active-controlled study of paliperidone extended-release as maintenance treatment in patients with bipolar I disorder after an acute manic or mixed episode, Journal of Affective Disorders, 2012, 138, 3, 247

    CrossRef

  16. 16
    Gin S Malhi, Danielle M Bargh, Roger McIntyre, Michael Gitlin, Mark A Frye, Michael Bauer, Michael Berk, Balanced efficacy, safety, and tolerability recommendations for the clinical management of bipolar disorder, Bipolar Disorders, 2012, 14,
  17. 17
    Marc De Hert, Weiping Yu, Johan Detraux, Kim Sweers, Ruud van Winkel, Christoph U. Correll, Body Weight and Metabolic Adverse Effects of Asenapine, Iloperidone, Lurasidone and Paliperidone in the Treatment of Schizophrenia and Bipolar Disorder, CNS Drugs, 2012, 26, 9, 733

    CrossRef

  18. 18
    Roger S McIntyre, Jinju Yoon, Efficacy of antimanic treatments in mixed states, Bipolar Disorders, 2012, 14,
  19. 19
    Konstantinos N. Fountoulakis, Siegfried Kasper, Ole Andreassen, Pierre Blier, Ahmed Okasha, Emanuel Severus, Marcio Versiani, Rajiv Tandon, Hans-Jürgen Möller, Eduard Vieta, Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry, European Archives of Psychiatry and Clinical Neuroscience, 2012, 262, S1, 1

    CrossRef

  20. 20
    Cecilio Álamo, Francisco López-Muñoz, Eficacia de quetiapina de liberación prolongada en la sintomatología afectiva, Revista de Psiquiatría y Salud Mental, 2012, 5, 3

    CrossRef

  21. 21
    Pierre-Michel Llorca, Thomas Charpeaud, Ludovic Samalin, États mixtes, L'Encéphale, 2012, 38, S179

    CrossRef

  22. 22
    Joris Berwaerts, Haiyan Xu, Isaac Nuamah, Pilar Lim, David Hough, Evaluation of the efficacy and safety of paliperidone extended-release in the treatment of acute mania: A randomized, double-blind, dose-response study, Journal of Affective Disorders, 2012, 136, 1-2, e51

    CrossRef

  23. 23
    Alessandra M.A. Nivoli, Andrea Murru, José M. Goikolea, José M. Crespo, José M. Montes, Ana González-Pinto, Paz García-Portilla, Julio Bobes, Jerónimo Sáiz-Ruiz, Eduard Vieta, New treatment guidelines for acute bipolar mania: A critical review, Journal of Affective Disorders, 2012, 140, 2, 125

    CrossRef

  24. 24
    Leslie Citrome, Oral paliperidone extended-release: chemistry, pharmacodynamics, pharmacokinetics and metabolism, clinical efficacy, safety and tolerability, Expert Opinion on Drug Metabolism & Toxicology, 2012, 8, 7, 873

    CrossRef

  25. 25
    Sheng-Min Wang, Changsu Han, Soo-Jung Lee, Ashwin A. Patkar, Chi-Un Pae, W. Wolfgang Fleischhacker, Paliperidone, Clinical Drug Investigation, 2012, 32, 8, 497

    CrossRef

  26. 26
    Sheng-Min Wang, Changsu Han, Soo-Jung Lee, Ashwin A. Patkar, Chi-Un Pae, W. Wolfgang Fleischhacker, Paliperidone, Clinical Drug Investigation, 2012, 32, 8, 497

    CrossRef

  27. 27
    Kimberly A. Stigler, Jennifer E. Mullett, Craig A. Erickson, David J. Posey, Christopher J. McDougle, Paliperidone for irritability in adolescents and young adults with autistic disorder, Psychopharmacology, 2012, 223, 2, 237

    CrossRef

  28. 28
    Konstantinos N. Fountoulakis, Dimitrios Kontis, Xenia Gonda, Melina Siamouli, Lakshmi N. Yatham, Treatment of mixed bipolar states, The International Journal of Neuropsychopharmacology, 2012, 15, 07, 1015

    CrossRef

  29. 29
    J.-M. Azorin, Trouble bipolaire : la pathologie intercritique, L'Encéphale, 2012, 38, S147

    CrossRef

  30. 30
    Paul E. Keck, Susan L. McElroy, John M. Hawkins, Bipolar Disorder, Psychopharm Review, 2011, 46, 4, 25

    CrossRef

  31. 31
    Konstantinos N Fountoulakis, Xenia Gonda, Eduard Vieta, Zoltan Rihmer, Class effect of pharmacotherapy in bipolar disorder: fact or misbelief?, Annals of General Psychiatry, 2011, 10, 1, 8

    CrossRef

  32. 32
    Shefali Srivastava, Terence A. Ketter, Clinical Relevance of Treatments for Acute Bipolar Disorder: Balancing Therapeutic and Adverse Effects, Clinical Therapeutics, 2011, 33, 12, B40

    CrossRef

  33. 33
    Ayşegül Yildiz, Eduard Vieta, Stefan Leucht, Ross J Baldessarini, Efficacy of Antimanic Treatments: Meta-analysis of Randomized, Controlled Trials, Neuropsychopharmacology, 2011, 36, 2, 375

    CrossRef

  34. 34
    Ayşegül Yildiz, Eduard Vieta, Mauricio Tohen, Ross J. Baldessarini, Factors modifying drug and placebo responses in randomized trials for bipolar mania, The International Journal of Neuropsychopharmacology, 2011, 14, 07, 863

    CrossRef

  35. 35
    Joris Berwaerts, Rosanne Lane, Isaac F. Nuamah, Pilar Lim, Bart Remmerie, David W. Hough, Paliperidone extended-release as adjunctive therapy to lithium or valproate in the treatment of acute mania: A randomized, placebo-controlled study, Journal of Affective Disorders, 2011, 129, 1-3, 252

    CrossRef

  36. 36
    Eduard Vieta, Terciarismo en psiquiatría: el Programa de Trastornos Bipolares del Clínic de Barcelona, Revista de Psiquiatría y Salud Mental, 2011, 4, 1, 1

    CrossRef

  37. 37
    Eduard Vieta, Tertiarism in psychiatry: Barcelona Clínic Bipolar Disorders Programme, Revista de Psiquiatría y Salud Mental (English Edition), 2011, 4, 1, 1

    CrossRef

  38. 38
    Carla M Canuso, Wendy P Battisti, Paliperidone extended-release: a review of efficacy and tolerability in schizophrenia, schizoaffective disorder and bipolar mania, Expert Opinion on Pharmacotherapy, 2010, 11, 15, 2557

    CrossRef

  39. 39
    Rif S. El-Mallakh, Mark S. Bauer, Bipolar (Manic Depressive) Disorders,
  40. 40
    Keming Gao, David E. Kemp, Renrong Wu, Joseph R. Calabrese, Mood Stabilizers,
  41. 41
    L. Ivo Caers, Joris Berwaerts, Risperidone and Paliperidone in the Treatment of Bipolar Disorder,